Pages that link to "Q48739730"
Jump to navigation
Jump to search
The following pages link to Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates (Q48739730):
Displaying 50 items.
- Educational interventions for the management of cancer-related fatigue in adults (Q24241242) (← links)
- Psychosocial interventions for reducing fatigue during cancer treatment in adults (Q24241509) (← links)
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline (Q26773986) (← links)
- Association of catastrophizing and fatigue: a systematic review (Q26851778) (← links)
- Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy (Q26863511) (← links)
- A cross-sectional investigation of fatigue in advanced renal cell carcinoma treatment: results from the FAMOUS study (Q30317588) (← links)
- A randomised controlled trial of the effect of music therapy and verbal relaxation on chemotherapy‐induced anxiety (Q30400533) (← links)
- Pilot study of cranial stimulation for symptom management in breast cancer (Q30432910) (← links)
- Cancer fatigue--more data, less information? (Q30695951) (← links)
- Distribution and determinants of patient satisfaction in oncology with a focus on health related quality of life (Q33511664) (← links)
- The effect of symptom clusters on functional status and quality of life in women with breast cancer (Q33699302) (← links)
- Symptom clusters in adults with chronic health problems and cancer as a comorbidity (Q33741102) (← links)
- Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments (Q33907387) (← links)
- Predictors of the intensity of symptoms in a cluster in patients with breast cancer. (Q33908488) (← links)
- Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine (Q34036124) (← links)
- Changes in daily activities of cancer patients after diagnosis: how do canadian and Iranian patients perceive the change? (Q34082514) (← links)
- A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Resear (Q34139127) (← links)
- Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapy (Q34148491) (← links)
- Correction of Low Vitamin D Improves Fatigue: Effect of Correction of Low Vitamin D in Fatigue Study (EViDiF Study) (Q34153372) (← links)
- Considerations for Training Cancer Survivors (Q34285948) (← links)
- Progress in understanding fatigue associated with breast cancer treatment (Q34385429) (← links)
- Fatigue management: evidence and guidelines for practice (Q34400142) (← links)
- New agents for the treatment of cancer-related fatigue (Q34400149) (← links)
- Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions (Q34467032) (← links)
- Adherence to intravenous chemotherapy in African American and white women with early-stage breast cancer (Q34514230) (← links)
- The measurement, causes and effective management of cancer-related fatigue (Q34581994) (← links)
- TNF/TNFR1 signaling mediates doxorubicin-induced diaphragm weakness (Q34598773) (← links)
- Behavioral symptoms in patients with breast cancer and survivors (Q34675620) (← links)
- Research into fatigue (Q34778954) (← links)
- Fatigue, Sleep, Pain, Mood, and Performance Status in Patients With Multiple Myeloma (Q34905283) (← links)
- The relationship between fatigue and light exposure during chemotherapy (Q35079843) (← links)
- Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer (Q35079859) (← links)
- Effects of aerobic exercise on cancer-related fatigue in breast cancer patients receiving chemotherapy: a meta-analysis (Q35103067) (← links)
- Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome (Q35124414) (← links)
- Low heart rate variability and cancer-related fatigue in breast cancer survivors (Q35130621) (← links)
- Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress (Q35222202) (← links)
- Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? (Q35229735) (← links)
- The assessment of fatigue: a practical guide for clinicians and researchers. (Q35689136) (← links)
- Pathophysiology of cancer-related fatigue (Q35763344) (← links)
- Fatigue and herpesvirus latency in women newly diagnosed with breast cancer (Q35816618) (← links)
- Fatigue and cancer: causes, prevalence and treatment approaches (Q35828557) (← links)
- Identification of distinct fatigue trajectories in patients with breast cancer undergoing adjuvant chemotherapy (Q35894091) (← links)
- Predicting survival in prostate cancer: the role of quality of life assessment (Q35928780) (← links)
- Fatigued breast cancer survivors: the role of sleep quality, depressed mood, stage and age. (Q36086537) (← links)
- An exploration of men's experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol (Q36092676) (← links)
- Randomized sham controlled trial of cranial microcurrent stimulation for symptoms of depression, anxiety, pain, fatigue and sleep disturbances in women receiving chemotherapy for early-stage breast cancer (Q36096344) (← links)
- Fatigue, depression, sleep, and activity during chemotherapy: daily and intraday variation and relationships among symptom changes (Q36205810) (← links)
- Cancer-related fatigue--mechanisms, risk factors, and treatments (Q36332266) (← links)
- Fatigue in breast cancer patients on adjuvant treatment: course and prevalence (Q36336088) (← links)
- A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancer (Q36409534) (← links)